Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients.
Nino N, Ishida T, Nakatani N, Lin KS, Win KHN, Mon CY, Nishimura A, Inoue S, Tamura A, Yamamoto N, Uemura S, Saito A, Mori T, Hasegawa D, Kosaka Y, Nozu K, Nishimura N.
Nino N, et al. Among authors: inoue s.
Heliyon. 2022 Oct 8;8(10):e10978. doi: 10.1016/j.heliyon.2022.e10978. eCollection 2022 Oct.
Heliyon. 2022.
PMID: 36276741
Free PMC article.